Join
Live feed
·
PRReleasevia Quantisnow
Hoth Therapeutics Inc. logo

Hoth Therapeutics Secures European Authorization in Spain for HT-001 Phase 2a Trial as Interim Data Show Strong Efficacy in Cancer Patients

ByQuantisnow·Wall Street's wire, on your screen.
HOTH· Hoth Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HOTH (Hoth Therapeutics Inc.) and more on Quantisnow.